FDFT1 and non-small cell lung carcinoma: However, NSCLC patients with a high expression of the key genes HMGCS1, HMGCR and FDFT1 of the MVA pathway had a poor survival rate, depicted by the TCGA database (Supplementary Fig. S5D–F).